ADIPOQ and type 2 diabetes mellitus: Furthermore, it has been previously reported that adiponectin expression is decreased by 20–40% in the presence of NAFLD, and plasma adiponectin concentrations are inversely related to hepatic fat content in patients with type 2 diabetes mellitus [8].